Send to a Friend Font Size: Increase Decrease

CGEN and DSNKY Related Headlines

Oct 17, 2025 10:00AM DATROWAY plus rilvegostomig shows tumor responses in urothelial cancer trial
Oct 17, 2025 10:00AM DATROWAY® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial

CGEN and DSNKY Related Press Releases

Oct 17, 2025 10:00AM DATROWAY® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial

CGEN and DSNKY Related SEC Filings